| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.3 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.073 | 0.3 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |